MX2020009021A - Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco. - Google Patents

Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.

Info

Publication number
MX2020009021A
MX2020009021A MX2020009021A MX2020009021A MX2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A
Authority
MX
Mexico
Prior art keywords
detecting
assays
amount
drug antibody
methods
Prior art date
Application number
MX2020009021A
Other languages
English (en)
Inventor
Susan Richards
Ryan Grabert
Valerie Theobald
Yuanxin Xu
Jad Zoghbi
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2020009021A publication Critical patent/MX2020009021A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Abstract

Métodos y kits para detectar anticuerpos (por ejemplo, anticuerpos antifármaco). Estos métodos y kits permiten la detección, por ejemplo, de anticuerpos antifármaco en fluidos corporales humanos, tales como sangre, plasma y suero.
MX2020009021A 2014-02-11 2016-08-10 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco. MX2020009021A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461938556P 2014-02-11 2014-02-11

Publications (1)

Publication Number Publication Date
MX2020009021A true MX2020009021A (es) 2020-10-12

Family

ID=52684652

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016010413A MX2016010413A (es) 2014-02-11 2015-02-11 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
MX2020009021A MX2020009021A (es) 2014-02-11 2016-08-10 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016010413A MX2016010413A (es) 2014-02-11 2015-02-11 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.

Country Status (19)

Country Link
US (3) US9759732B2 (es)
EP (4) EP3667321B1 (es)
CN (1) CN106164670B (es)
AU (2) AU2015217261B2 (es)
CA (1) CA2939080A1 (es)
CY (1) CY1121341T1 (es)
DK (1) DK3105592T3 (es)
ES (1) ES2705403T3 (es)
HR (1) HRP20190026T1 (es)
HU (1) HUE041669T2 (es)
LT (1) LT3105592T (es)
MX (2) MX2016010413A (es)
PL (1) PL3105592T3 (es)
PT (1) PT3105592T (es)
RS (1) RS58212B1 (es)
SG (2) SG10201906750XA (es)
SI (1) SI3105592T1 (es)
TR (1) TR201900160T4 (es)
WO (1) WO2015123315A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3105592T (lt) 2014-02-11 2019-01-25 Genzyme Corporation Antikūnų prieš vaistus buvimo arba jų kiekio aptikimo analizė
EP2982987A1 (en) * 2014-08-08 2016-02-10 Proteomika, S.L. Lateral flow immunoassays for the detection of antibodies against biological drugs
US9927443B2 (en) * 2015-04-10 2018-03-27 Conquerab Inc. Risk assessment for therapeutic drugs
RU2725142C2 (ru) * 2015-10-15 2020-06-30 Биокон Лимитед Способ обнаружения нейтрализующих антител против рекомбинантного человеческого инсулина в сыворотке крови человека
JP6889160B2 (ja) 2015-12-16 2021-06-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ３段階酸解離酵素結合免疫吸着（ｔａｄｅｌｉｓ）アッセイ法
US9903866B2 (en) 2016-04-05 2018-02-27 Conquerab Inc. Portable devices for detection of antibodies against therapeutic drugs
EP3239711B1 (en) 2016-04-27 2019-12-25 JIMRO Co., Ltd. Method for measuring anti-drug antibody
JP7256172B2 (ja) * 2017-08-08 2023-04-11 エフ． ホフマン－ラ ロシュ アーゲー ミニブタ試料において抗薬物抗体を決定するための方法
KR102551444B1 (ko) * 2017-11-29 2023-07-06 에프. 호프만-라 로슈 아게 표적 간섭이 억제된 항-약물 항체 분석
CN109358192B (zh) * 2018-02-08 2020-05-12 中国科学院上海药物研究所 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用
IL307286A (en) * 2018-04-11 2023-11-01 Regeneron Pharma Methods and preparations for quantification of IL-33
WO2020014194A1 (en) * 2018-07-10 2020-01-16 Regeneron Pharmaceuticals, Inc. Methods for mitigating drug target interference in an anti-drug antibody (ada) immunoassay
CA3136161A1 (en) * 2019-04-16 2020-10-22 Laboratory Corporation Of America Holdings Methods and systems for detecting antibodies by surface plasmon resonance
KR20200124556A (ko) 2019-04-24 2020-11-03 삼성전자주식회사 펠리클 조립체의 제조 방법 및 포토마스크 조립체의 제조 방법
CN112285351A (zh) * 2019-07-22 2021-01-29 上海益诺思生物技术股份有限公司 一种抗IgE单抗的ELISA检测方法
WO2021046316A2 (en) * 2019-09-05 2021-03-11 Adverum Biotechnologies Anti-drug antibody assay
CN111171141A (zh) * 2020-01-20 2020-05-19 苏州药明康德新药开发有限公司 聚乙二醇在临床前安全性评价中的应用
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术（北京）有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
MX2022013738A (es) * 2020-05-01 2022-11-16 Regeneron Pharma Ensayo de anticuerpos neutralizantes para proteinas terapeuticas.
JP2022022524A (ja) * 2020-06-25 2022-02-07 シスメックス株式会社 Ａβペプチドの測定方法及びその方法に用いられる試薬組成物
US20230393144A1 (en) * 2020-10-14 2023-12-07 I-Mab Biopharma Us Limited Methods for mitigating interference by therapeutic anti-cd47 antibodies in pre-transfusion assays
JP7062803B1 (ja) 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
WO2023110918A1 (en) 2021-12-14 2023-06-22 Cdr-Life Ag Dual mhc-targeting t cell engager
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
WO2024052517A2 (en) 2022-09-09 2024-03-14 Bayer Aktiengesellschaft Medical use of ccr8 antibodies and dosing schedule
US20240091262A1 (en) 2022-09-14 2024-03-21 Cdr-Life Ag Mage-a4 peptide dual t cell engagers
CN115561355A (zh) * 2022-09-26 2023-01-03 重庆迪纳利医药科技有限责任公司 羧肽酶g2的中和抗体检测方法以及基于lc-ms/ms的检测系统
CN116699147A (zh) * 2023-08-04 2023-09-05 军科正源（北京）药物研究有限责任公司 检测总IgE含量的方法以及相关试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448632A1 (en) * 1988-12-09 1991-10-02 Centocor, Inc. Anti-idiotopic immunometric assay
US5187065A (en) * 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
ES2498377T3 (es) * 2006-03-09 2014-09-24 F. Hoffmann-La Roche Ag Ensayo de anticuerpos antifármaco
AU2008247352A1 (en) * 2007-05-07 2008-11-13 Wyeth Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
CA2712021A1 (en) * 2008-01-15 2009-07-23 Stichting Sanquin Bloedvoorziening Methods and kits for detecting antibodies against therapeutic antibodies
JP2010078374A (ja) 2008-09-24 2010-04-08 Olympus Corp 抗赤血球抗体の検出方法
US7799532B2 (en) * 2008-11-12 2010-09-21 Hemopet Detection and measurement of thyroid hormone autoantibodies
ES2530175T3 (es) 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
MX352118B (es) * 2012-03-08 2017-11-09 Hoffmann La Roche Metodo de inmunoanalisis cromatografico multiplexado para la caracterizacion de inmunocomplejos circulantes.
WO2015000865A1 (en) * 2013-07-04 2015-01-08 F. Hoffmann-La Roche Ag Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
LT3105592T (lt) 2014-02-11 2019-01-25 Genzyme Corporation Antikūnų prieš vaistus buvimo arba jų kiekio aptikimo analizė

Also Published As

Publication number Publication date
MX2016010413A (es) 2016-11-30
US11215623B2 (en) 2022-01-04
EP4137816A1 (en) 2023-02-22
CY1121341T1 (el) 2020-05-29
AU2015217261B2 (en) 2020-08-27
US11927596B2 (en) 2024-03-12
US9759732B2 (en) 2017-09-12
CN106164670B (zh) 2019-06-14
SI3105592T1 (sl) 2019-02-28
SG10201906750XA (en) 2019-09-27
EP3105592A1 (en) 2016-12-21
PT3105592T (pt) 2019-01-23
ES2705403T3 (es) 2019-03-25
SG11201606291VA (en) 2016-08-30
RS58212B1 (sr) 2019-03-29
EP3422001B1 (en) 2020-03-25
DK3105592T3 (en) 2019-02-04
EP3422001A1 (en) 2019-01-02
US20150226758A1 (en) 2015-08-13
CN106164670A (zh) 2016-11-23
CA2939080A1 (en) 2015-08-20
US20220187327A1 (en) 2022-06-16
HRP20190026T1 (hr) 2019-02-22
EP3105592B1 (en) 2018-10-17
EP3667321B1 (en) 2022-07-27
US20180088140A1 (en) 2018-03-29
TR201900160T4 (tr) 2019-02-21
PL3105592T3 (pl) 2019-04-30
WO2015123315A1 (en) 2015-08-20
LT3105592T (lt) 2019-01-25
EP3667321A1 (en) 2020-06-17
AU2015217261A1 (en) 2016-09-08
HUE041669T2 (hu) 2019-05-28
AU2020264316A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
PH12019501146A1 (en) Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
AU2018200278B2 (en) Antibodies to aripiprazole and use thereof
MA40390A (fr) Procédés d'analyse impliquant des nanoparticules dissociables
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
MX2016013261A (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
MX2016001573A (es) Ensayos para timp2 con mejor rendimiento en muestras biológicas.
EA201792289A1 (ru) Способы обнаружения агглютинации и композиции для их осуществления
EP3523639A4 (en) DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR DIAGNOSTIC MULTIANALYTE TEST ELEMENTS AND METHOD FOR USE THEREOF
PH12019501837A1 (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
SA518391028B1 (ar) Cd37 أجسام مضادة واختبارات للكشف عن
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
EP3415912A4 (en) ANALYT DETECTION PROCEDURE AND REAGENT SET TO DETECT ANALYTES
SG10201806729VA (en) Novel assay to detect human periostin
WO2014151290A3 (en) Assay for predictive biomarkers
MX2019011702A (es) Ensayos de inmunogenicidad mejorados.
EP3922983A3 (en) Improved low sample volume urinalysis assay strip, analytical kits, and methods of use related thereto
MY192159A (en) Method for detecting neutralizing antibodies against recombinant human insulin in human serum
EP3721229A4 (en) LATERAL FLOW ASSAY AND METHOD OF DETECTING HIGH CONCENTRATION ANALYTES
EP3207374A4 (en) Method and system for determining the concentration of an analyte in a fluid sample
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
EP3306319A4 (en) TEST OBJECT DETECTION METHOD, AND IMMUNOLOGICAL ASSAY INSTRUMENT AND MONOCLONAL ANTIBODY THEREOF
SG10201901836PA (en) Test strip assembly
EP3502271A3 (en) Blood biomarkers for appendicitis and diagnostics methods using biomarkers